BIOA Competitors & Alternatives

Compare BioAge Labs, Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BIOA

Main Stock
$5.87
Tradestie Score
45
Market Cap
$212.23M
Revenue Growth
-0.9%
Analyst Upside
+392.1%

Top Competitors

46 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$3.45
$1.02B 21.3 49 Compare
ZBIO Zenas BioPharma, Inc. Common Stock
$28.70
$931.48M - 53 Compare
MBX MBX Biosciences, Inc. Common Stock
$57.72
$800.41M - 36 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$68.40
$543.32M 41.7 49 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$10.31
$463.20M - 43 Compare
ALMS Alumis Inc. Common Stock
$6.62
$422.50M - 40 Compare
TKNO Alpha Teknova, Inc. Common Stock
$8.62
$340.89M - 40 Compare
KYTX Kyverna Therapeutics, Inc. Common Stock
$5.12
$258.18M - 48 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.87
$237.15M 5.3 48 Compare

Data updated: Nov 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

46 stocks in this industry